Mega Lifesciences stock heads into November 12 results date
Published on 11/11/2026 at 02:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMega Lifesciences approaches results date
- Mega Lifesciences is scheduled to release third-quarter 2026 results on November 12.
- First-half revenue rose 12.5%, while EBITDA increased 33.8% and reported net profit climbed 33.1%.
- Management has scheduled a conference call for November 13.
Mega Lifesciences is approaching a closely watched reporting date after a strong first half. The company is scheduled to announce its third-quarter 2026 results on Thursday, November 12, according to its investor-relations page.
The company reported that first-half operating revenue grew 12.5% year over year. EBITDA increased 33.8%, while reported net profit rose 33.1%. Adjusted net profit grew 11.7%, pointing to a stronger reported earnings performance than the adjusted figure.
Results will set the next market focus
The November release will give investors the next read on whether the first-half growth trend continued into the third quarter. The company has also scheduled an earnings conference call for Friday, November 13, followed by an investor presentation on December 1.
TradingView's financial-disclosure page describes the first half as a period of revenue growth, margin expansion and stronger profit gains led by Southeast Asia. The upcoming figures should therefore help investors assess the durability of the company's recent operating improvement.
Mega Lifesciences business profile
Mega Lifesciences develops and sells branded health products and operates a distribution business focused on emerging markets. Its investor-relations materials highlight Southeast Asia as a key source of first-half growth and identify branded business momentum as an important operating driver. The company is headquartered in Thailand and trades on the Stock Exchange of Thailand.
Mega Lifesciences at a glance
- Company: Mega Lifesciences Public Company Limited
- ISIN: TH0765010002
- First-half revenue growth: 12.5% year over year
- First-half EBITDA growth: 33.8% year over year
- First-half reported net profit growth: 33.1% year over year
- Next results: November 12, 2026
- Earnings call: November 13, 2026
Broader developments in Asian equity markets remain relevant for investors following the results. See Current market reports.
